Report Adverse Event or Product Quality Complaint   

Header Logo
  • Prescribing Information
  • Therapy areas
    • All Therapeutic Areas
    • Cardiovascular, Renal and Metabolism
    • Immunology
    • Infection
    • Oncology
    • Rare Disease (Alexion)
    • Respiratory
  • Disease Education
  • Resources
    • Congress Library
    • Clinical Trials
    • Continuing Education
    • Patient Support
    • Pipeline
    • Oncology Pipeline Tool
  • Connect
    • Connect with an MSL
    • Connect with an MSL
    • Submit an Medical Information Request
    • Give Feedback

Search Medical Information

Login

Request a field medical follow-up

  • Home
  • Congress Library
  • ACG 2026

American College of Gastroenterology (ACG) Congress - 2026

October 9 - 14, 2026

  1. All
  2. TEZSPIRE (tezepelumab)

HTML

Disease severity and real-world treatment patterns among patients with eosinophilic esophagitis in the United States: A retrospective observational study

HTML

Real-world healthcare resource utilization and clinical presentations among patients with eosinophilic esophagitis following swallowed topical corticosteroid or biologic initiation

HTML

Real-world treatment patterns, symptom burden, and unmet needs in patients with eosinophilic esophagitis: A cross-sectional study in Europe and the United States

HTML

Estimating the meaningful change threshold for the Dysphagia Symptom Questionnaire (DSQ): Analysis of blinded data from the CROSSING trial

HTML

Efficacy and safety of tezepelumab in adults and adolescents with eosinophilic esophagitis: Results from the phase 3 CROSSING study

HTML

Disease severity and real-world treatment patterns among patients with eosinophilic esophagitis in the United States: A retrospective observational study

HTML

Real-world healthcare resource utilization and clinical presentations among patients with eosinophilic esophagitis following swallowed topical corticosteroid or biologic initiation

HTML

Real-world treatment patterns, symptom burden, and unmet needs in patients with eosinophilic esophagitis: A cross-sectional study in Europe and the United States

HTML

Estimating the meaningful change threshold for the Dysphagia Symptom Questionnaire (DSQ): Analysis of blinded data from the CROSSING trial

HTML

Efficacy and safety of tezepelumab in adults and adolescents with eosinophilic esophagitis: Results from the phase 3 CROSSING study

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

Connessiallasalute.it

This site is intended for healthcare professionals practicing in the US.
©2026 AstraZeneca. All rights reserved.

US-115625
Last Updated 9/26

Contact Us

About Us

AstraZeneca-US.com

Other Countries

Grant Opportunities  

Survey Feedback

Your Privacy Choice

Consumer Health Data
Privacy Notice

Privacy Notice | Legal Notice | Cookie Preferences

Welcome to AstraZeneca Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

 

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

 

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?
This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States